O26.64
Intrahepatic cholestasis of pregnancy
Clinical Classification Guidelines
Use Additional Code
- code for hepatic obstruction (K76.89)
Medical Intelligence & Overview
Intrahepatic cholestasis of pregnancy (ICP) is a liver disorder that occurs during pregnancy. It is characterized by impaired flow of bile from the liver, leading to a buildup of bile acids in the bloodstream. This condition typically manifests during the second or third trimester and can pose risks to both the mother and the baby if not properly managed. Recognizing the symptoms and understanding the causes and treatment options are important steps for managing this condition effectively.
Causes & Symptoms
Clinical Causes: Hormonal changes during pregnancy, especially elevated levels of estrogen and progesterone Genetic predisposition or family history of liver disorders Pre-existing liver conditions or liver dysfunction Environmental factors such as dietary deficiencies or exposure to certain toxins
Key Symptoms: Intense itching, especially on the palms of the hands and soles of the feet Jaundice (yellowing of the skin and eyes) Dark urine Light-colored stools Fatigue and malaise Loss of appetite Nausea
Diagnostic & Treatment
Diagnosis Path: Diagnosis of intrahepatic cholestasis of pregnancy involves a combination of clinical evaluation and laboratory tests. Healthcare providers typically perform the following: - Blood tests to measure liver function and bile acids levels - Urinalysis to check for bilirubin - Ultrasound to rule out other liver or biliary conditions - Monitoring of symptoms over time, especially the characteristic itching Diagnostic criteria focus on elevated serum bile acids and abnormal liver enzyme levels alongside clinical symptoms, particularly significant itching without other causes.
Treatment Protocols: Management of intrahepatic cholestasis aims to reduce symptoms and minimize risks to the fetus. Treatment options include: - Use of medications like ursodeoxycholic acid to lower bile acids and improve liver function - Regular monitoring of maternal liver function tests and fetal well-being - Planning for early delivery, often around 37-38 weeks, to prevent complications - Safe skin soothing measures to alleviate itching - Maintaining a healthy diet and avoiding substances that may worsen liver conditions It is essential to have a healthcare team coordinate the approach to ensure maternal comfort and fetal safety throughout the pregnancy.
Clinical Advice & FAQs
Billing Guidance
Is O26.64 a billable ICD-10 code?
Yes, O26.64 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report O26.64?
Clinical documentation must specify the nature of Intrahepatic cholestasis of pregnancy and any associated comorbidities for accurate reporting.
Cite this Clinical Reference